[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338381-105":59,"doc-detail-338381-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glioma-associated-oncogene-homolog-1-in-breast-invasive-carcinoma-a-comprehensive-bioinformatic-analysis-and-experimental-validation","Glioma-associated oncogene homolog 1 in breast invasive carcinoma - a comprehensive bioinformatic analysis and experimental validation","","Breast invasive carcinoma remains a major cause of cancer-related deaths despite treatment advances, and GLI1’s immune-regulatory role in this disease is not well defined. This study determines GLI1 expression patterns in BRCA using TCGA/GTEx-based bioinformatics and compares cancer-wide dysregulation. Clinical validation includes qPCR and immunohistochemistry. Prognostic relevance is assessed by Kaplan–Meier and Cox analyses, alongside links between GLI1 expression and tumor immune microenvironment immune infiltration and immune-related pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glioma-associated-oncogene-homolog-1-in-breast-invasive-carcinoma-a-comprehensive-bioinformatic-analysis-and-experimental-validation/338381/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glioma-associated-oncogene-homolog-1-in-breast-invasive-carcinoma-a-comprehensive-bioinformatic-analysis-and-experimental-validation/338381.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main goal of the study on GLI1 in breast invasive carcinoma?","Question",{"text":112,"@type":113},"To clarify GLI1 expression patterns and determine its immune-regulatory and prognostic roles in breast invasive carcinoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was GLI1 expression assessed in BRCA?",{"text":117,"@type":113},"Using multiple bioinformatic platforms based on TCGA and/or GTEx databases, followed by experimental validation in clinical BRCA samples using qPCR and immunohistochemical staining.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the relationship between GLI1 and the tumor immune microenvironment?",{"text":121,"@type":113},"GLI1 expression correlates with immune and stromal scores and with infiltration levels of multiple immune cell types, and it is linked to activation of immune-related pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338381,1790331868,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 17 October 2024 DOI 10.3389/fcell.2024.1478478  \nOPEN ACCESS  \nEDITED BY  \nXiaosheng Tan,  \nRutgers, United States  \nREVIEWED BY  \nYang Li,  \nAlbert Einstein College of Medicine, United States  \nYancui Sun,  \nDalian Medical University, China Laixing Zhang,  \nUniversity of California, Los Angeles, United States  \nMeng Jia,  \nUniversity of Pennsylvania, United States  \n*CORRESPONDENCE  \nHe Wu,  \n [hewu6768@gmail.com](hewu6768@gmail.com)[ ](hewu6768@gmail.com)Yonggang Lv,  \n [lvygwytt@163.com](lvygwytt@163.com)[ ](lvygwytt@163.com)Fuqing Ji,  \n [jifuqing1984@126.com](jifuqing1984@126.com)  \nRECEIVED 09 August 2024  \nACCEPTED 04 October 2024  \nPUBLISHED 17 October 2024  \nCITATION  \nQiT, Hu Y, Wan J, Zhao B, Xiao J, Liu J, Cheng Y, Wu H, Lv Y and Ji F (2024) Glioma-associated oncogene homolog 1 in breast invasive carcinoma: a comprehensive bioinformatic analysis and experimental validation.  \nFront. Cell Dev. Biol. 12:1478478 .  \ndoi: 10.3389/fcell.2024.1478478  \nCOPYRIGHT  \n© 2024 Qi, Hu, Wan, Zhao, Xiao, Liu, Cheng, Wu, Lv and Ji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nGlioma-associated oncogene homolog 1 in breast invasive carcinoma: a comprehensive bioinformatic analysis and experimental validation  \nTeng Qi 1, Yujie Hu 1, Junhao Wan 1, Bo Zhao 1, Jinsuo Xiao 1,  \nJie Liu 2, Ye Cheng 2, He Wu 2*, Yonggang Lv 1,2* and Fuqing Ji 2* 1School of Medicine, Northwest University, Xi’an, Shaanxi, China, 2Xi’an NO.3 Hospital, The Afﬁliated Hospital of Northwest University, Xi’an, Shaanxi, China  \nBackground: Breast cancer, despite signiﬁcant advancements in treatment, remains a major cause of cancer-related deaths among women. Immunotherapy, an emerging therapeutic strategy, offers promise for better outcomes, particularly through the modulation of immune functions. GliomaAssociated Oncogene Homolog 1 (GLI1), a transcription factor implicated in cancer biology, has shown varying roles in different cancers. However, its immunoregulatory functions in breast invasive carcinoma (BRCA) remain elusive. The current study aimed to unravel the expression patterns and immune-regulatory roles of GLI1 in BRCA.  \nMethods: Utilizing multiple bioinformatic platforms (TIMER2 . 0, GEPIA2, and R packages) based on The Cancer Genome Atlas (TCGA) and/or Genotype-Tissue Expression (GTEx) databases, we analyzed the expression of GLI1 in BRCA and itspan-cancer expression proﬁles. We further validated these ﬁndings by conducting qPCR and immunohistochemical staining on clinical BRCA samples. Kaplan-Meier analysis and Cox proportional hazards regression were performed to assess the prognostic value of GLI1 . Additionally, the association between GLI1 expression and immune inﬁltration within the tumor immune microenvironment (TMIE) was examined.  \nResults: The ﬁndings reveal dysregulated expression of GLI1 in numerous cancers, with a signiﬁcant decrease observed in BRCA. High GLI1 expression indicated better survival outcomes and was correlated with the age and stage of BRCA patients. GLI1 was involved in immune status, as evidenced by its strong correlations with immune and stromal scores and the inﬁltration levels of multiple immune cells. Meanwhile, GLI1 was co-expressed with multiple immune-related genes, and high GLI1 expression was associated with the activation of immunerelated pathways, such as binding to proteasome and mismatch repair and retinol metabolism signaling pathways. Additionally, the differential expression of GLI1 may be related to the effect of immunotherapy on CTLA-4, PD-1, and other signals, and can ef","cbCaisnXInFsVHF8","https://ap.wps.com/l/cbCaisnXInFsVHF8","pdf",6309569,15,"English","# Background\n# Methods\n## Data mining and bioinformatics\n## Experimental validation and statistical analyses\n# Results\n## Expression and clinical associations\n## Immune microenvironment correlations\n## Pathway enrichment and immune-response prediction\n# Conclusion","[{\"question\":\"What was the main goal of the study on GLI1 in breast invasive carcinoma?\",\"answer\":\"To clarify GLI1 expression patterns and determine its immune-regulatory and prognostic roles in breast invasive carcinoma.\"},{\"question\":\"How was GLI1 expression assessed in BRCA?\",\"answer\":\"Using multiple bioinformatic platforms based on TCGA and/or GTEx databases, followed by experimental validation in clinical BRCA samples using qPCR and immunohistochemical staining.\"},{\"question\":\"What is the relationship between GLI1 and the tumor immune microenvironment?\",\"answer\":\"GLI1 expression correlates with immune and stromal scores and with infiltration levels of multiple immune cell types, and it is linked to activation of immune-related pathways.\"}]","Glioma-associated oncogene homolog 1 in breast invasive carcinoma - a comprehensive bioinformatic analysis and experimental validation | PDF",1790023363,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7214b953c82a74dd3c01e17860e4b27b.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d0abd980f406e6de3b3315c9fc62524.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7dedb8217ddac31de43516c3ed48a18d.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86b2199c76f1dbcf989ee68804a43230.webp",980,1385]